Relay Therapeutics, Inc. RLAY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$272.71M+18.2% | -$276.48M+18.1% | -$297.59M+13.8% | -$311.55M+3.5% | -$333.39M-1.3% | ||
| $2.85M-45.9% | $3.56M-34.9% | $4.29M-22.0% | $4.91M-10.7% | $5.28M-3.5% | ||
| $53.63M-37.8% | $62.42M-33.7% | $66.99M-30.1% | $73.94M-22.3% | $86.28M-5.9% | ||
| -$213.36M+21.6% | -$235.46M+5.5% | -$248.46M+11.4% | -$261.42M+6.9% | -$271.99M+4.1% | ||
| —— | $411K-79.6% | $410K-80.8% | $637K-74.5% | $622K-84.4% | ||
| $183.24M— | $192.8M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$59.91M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Relay Therapeutics, Inc. generate?
- Relay Therapeutics, Inc. (RLAY) generated -$213.4M in operating cash flow over the trailing twelve months.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
